Search research articles
Contact Us
Filters
Showing results (531-540 of 754) with videos related to
Page
of 76
Sort By:
The New England Journal of Medicine
|
November 27, 2009
A sensitive cardiac troponin T assay in stable coronary artery disease
Torbjørn Omland, James A de Lemos, Marc S Sabatine, et al.
American Heart Journal
|
August 10, 2005
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)
Shelby D Reed, Jasmina I Radeva, Kevin P Weinfurt, et al.
Circulation
|
June 15, 2007
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Eileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
American Heart Journal
|
October 11, 2011
Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both
Amil M Shah, Chung-Lieh Hung, Sung Hee Shin, et al.
JACC. Heart Failure
|
April 11, 2021
Worsening Heart Failure Episodes Outside a Hospital Setting in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial
Muthiah Vaduganathan, Jonathan W Cunningham, Brian L Claggett, et al.
European Journal of Heart Failure
|
October 23, 2024
Visit-to-visit changes in heart rate in heart failure: A pooled participant-level analysis of the PARADIGM-HF and PARAGON-HF trials
Henri Lu, Brian L Claggett, Milton Packer, et al.
Circulation. Heart Failure
|
June 22, 2019
Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction
Senthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
American Heart Journal
|
October 8, 2005
Prognostic use of echocardiography 1 year after a myocardial infarction
Hicham Skali, Leonardo A M Zornoff, Marc A Pfeffer, et al.
Journal of the American College of Cardiology
|
April 17, 2026
Interchangeability of the KCCQ-12 and KCCQ-23 Across >18,000 Participants Enrolled in 4 Large-Scale Trials of Heart Failure
Yasuhiro Hamatani, Brian L Claggett, Akshay S Desai, et al.
ESC Heart Failure
|
December 24, 2022
Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure
Jean-Claude Tardif, Jean Rouleau, Glenn M Chertow, et al.
Page
of 76
Search research articles
Search
Showing results (531-540 of 754) with videos related to
Sort By:
Page
of 76
The New England Journal of Medicine
|
November 27, 2009
A sensitive cardiac troponin T assay in stable coronary artery disease
Torbjørn Omland, James A de Lemos, Marc S Sabatine, et al.
American Heart Journal
|
August 10, 2005
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)
Shelby D Reed, Jasmina I Radeva, Kevin P Weinfurt, et al.
Circulation
|
June 15, 2007
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Eileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
American Heart Journal
|
October 11, 2011
Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both
Amil M Shah, Chung-Lieh Hung, Sung Hee Shin, et al.
JACC. Heart Failure
|
April 11, 2021
Worsening Heart Failure Episodes Outside a Hospital Setting in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial
Muthiah Vaduganathan, Jonathan W Cunningham, Brian L Claggett, et al.
European Journal of Heart Failure
|
October 23, 2024
Visit-to-visit changes in heart rate in heart failure: A pooled participant-level analysis of the PARADIGM-HF and PARAGON-HF trials
Henri Lu, Brian L Claggett, Milton Packer, et al.
Circulation. Heart Failure
|
June 22, 2019
Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction
Senthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
American Heart Journal
|
October 8, 2005
Prognostic use of echocardiography 1 year after a myocardial infarction
Hicham Skali, Leonardo A M Zornoff, Marc A Pfeffer, et al.
Journal of the American College of Cardiology
|
April 17, 2026
Interchangeability of the KCCQ-12 and KCCQ-23 Across >18,000 Participants Enrolled in 4 Large-Scale Trials of Heart Failure
Yasuhiro Hamatani, Brian L Claggett, Akshay S Desai, et al.
ESC Heart Failure
|
December 24, 2022
Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure
Jean-Claude Tardif, Jean Rouleau, Glenn M Chertow, et al.
Page
of 76